Camrelizumab combined with transcatheter arterial chemoembolization and sorafenib or lenvatinib for unresectable hepatocellular carcinoma: A multicenter, retrospective study Xiumei Jiang; Pan Wang; Ke Su; Han Li; Hao Chi; Fei Wang; Yu Liu; Ke Xu;

Surveillance and management of hepatocellular carcinoma after treatment of hepatitis C with direct-acting antiviral drugs Caiyun Yang; Fengxiang Lv; Jiaqi Yang; Dawei Ding; Lina Cui; Ying Han;

Prognostic factors influencing outcomes in hepatocellular carcinoma patients undergoing selective internal radiation therapy Maria Stella Franzè; Paul Vigneron; Anna Sessa; Carlo Saitta; Julia Chalaye; Vania Tacher; Alain Luciani; Hélène Regnault; Ancuta Bejan; Rami Rhaiem; Daniele Sommacale; Vincent Leroy; Raffaele Brustia; Giovanni Raimondo; Giuliana Amaddeo;